SCHEMBL6749486

SCHEMBL6749486

CC[SiH2]c1ccc(N(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
MAPT P10636 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
KDM4E B2RXH2 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
CRHBP P24387 1/20 0.39
ATM Q13315 1/20 0.39
CRHR2 Q13324 1/20 0.39
TLR9 Q9NR96 1/20 0.39
TSHR P16473 2/20 0.36
GLA P06280 1/20 0.36
HDAC6 Q9UBN7 1/20 0.34
APP P05067 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8688470 0.92 CYP2C19 (0.43) ALDH1A1MAPTL3MBTL1TDP1KDM4E
SCHEMBL8689578 0.83 ALDH1A1 (0.41) ALDH1A1MAPTTDP1CYP2C19TSHR
SCHEMBL8694181 0.81 PTGS2 (0.43) ALDH1A1MAPTL3MBTL1KDM4ECYP2D6
SCHEMBL311787 0.81
Fluoride SCHEMBL27930946 0.79 TP53 (0.39) ALDH1A1MAPTL3MBTL1MEN1KMT2A
SCHEMBL8690516 0.77 ALDH1A1 (0.50) ALDH1A1MAPTL3MBTL1TDP1KDM4E
SCHEMBL36869 0.75 ALDH1A1 (0.72) ALDH1A1MAPTL3MBTL1TDP1KDM4E
SCHEMBL12333623 0.75 ALDH1A1 (0.72) ALDH1A1MAPTL3MBTL1TDP1KDM4E
SCHEMBL17087772 0.75 ALDH1A1 (0.72) ALDH1A1MAPTL3MBTL1TDP1KDM4E
SCHEMBL13720763 0.75 ALDH1A1 (0.72) ALDH1A1MAPTL3MBTL1TDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-9263754-A None JP disclosed
US-6696588-B2 OXIDATION POTENTIAL OF .3-1.5 V ON THE BASIS OF A STANDARD HYDROGEN ELECTRODE, ALKOXY AND AROMATIC AMINE DERIVATIVES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-02-24 US disclosed
EP-0861845-B1 Silicon-containing compound and organic electroluminescence device using the same SUMITOMO CHEMICAL CO (JP) 2003-05-28 EP disclosed
US-20020115877-A1 Silicon-containing compound and organic electroluminescence device using the same SUMITOMO CHEMICAL COMPANY, LIMITED 2002-08-22 US disclosed
EP-0786924-B1 Organic electroluminescence device SUMITOMO CHEMICAL CO (JP) 2002-04-17 EP disclosed
US-6369258-B1 SILICON COMPOUND WITH OXIDATION POTENTIAL ON HYDROGEN ELECTRODE POTENTIAL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-04-09 US disclosed
US-5958609-A HOLE TRANSPORTING MATERIAL CONTAINS AT LEAST ONE POLYSILANE SUMITOMO CHEMICAL CO., LTD. (JP) 1999-09-28 US disclosed
US-5830972-A PHOTOCONDUCTOR SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1998-11-03 US disclosed
EP-0861845-A2 Silicon-containing compound and organic electroluminescence device using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1998-09-02 EP disclosed
JP-H09263754-A ORGANIC ELECTROLUMINESCENT ELEMENT SUMITOMO CHEM CO LTD 1997-10-07 JP disclosed
EP-0786924-A1 Organic electroluminescence device SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1997-07-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020115877-A1 Silicon-containing compound and organic electroluminescence device using the same EPCAM, PIEZO1, OR10J3 ALDH1A1 460/4885MAPT 1203/4885L3MBTL1 2398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.